feed
view company updates
tools
perform investment research
network
join events & discussions
advisory
about us
Redeye Capital
Asarina Pharma: Discouraging Results in Menstrual Migraine
Redeye reckons negative results in Menstrual Migraine (MM) and excludes this project from our valuation.
AH
Anders Hedlund
Disclosures and disclaimers
Premium Plan required to unlock
Unlock companies to access
more high quality research.
View Plans